Allarity Therapeutics A/S equity rights TO 3 have an Extraordinary Exercise
Period between 30 August 2021 - 13 September 2021. The Extraordinary Exercise
Period terminates the subsequent exercise periods.
Security name: Allarity Therapeutics TO 3
------------------------------------------
Short name: ALLR TO 3
------------------------------------------
ISIN code: DK0061552270
------------------------------------------
Orderbook ID: 229349
------------------------------------------
Terms: One (1) warrant of series TO 3 gives the holder the right to subscribe
for one (1) new share in Allarity Therapeutics A/S during the
subscription period stated below. The subscription price shall be SEK
1,70 per share.
The board of directors have, in accordance with previously communicated
entitlement based on the increase in the Company's shares to SEK 2,00
or more calculated as average VWAP over 10 trading days, determined an
extraordinary exercise window of 10 trading days in which warrants
shall be exercised. Warrants that are not exercised in the exercise
window thus determined shall become null and void without compensation
or payment of any kind to the Warrant holders. In the event that the
price of the Company's shares should decrease to less than SEK 2,00
during the exercise window, the board of directors shall at its
discretion be entitled to cancel the extraordinary exercise window and
the warrants shall following such cancellation remain in full force and
effect. Any funds paid to the Company prior to such cancellation shall
be repaid.
--------------------------------------------------------------------------------
Subscr The Warrants may be exercised in the exercise window as follows:
iption 30 August 2021 - 13 September 2021
perio
d:
--------------------------------------------------------------------------------
Last 9 September 2021
tradi
ng
day:
--------------------------------------------------------------------------------
This information is distributed at the request of the Certified Adviser, Svensk
Kapitalmarknadsgranskning AB. For further information, please call Svensk
Kapitalmarknadsgranskning AB +46 11 32 30 732.© 2021 GlobeNewswire
